The Independent reports on research flagging deficiencies in GLP-1 users, as close to 30 million Americans now take these drugs.
Recap by typeshit. Full story at The Independent on MSN.
Peptide talk is everywhere from YouTube to Reddit. CNBC looks at what is actually known about their safety.
The post warns that people in their 50s and 60s may blame vision changes on age or screens, when researchers have tied the drug in Ozempic to a rare cause of sudden sight loss.
Facial fat loss during GLP-1 weight loss can mean hollowing, flatter cheeks and looser skin, and Dr. Makkani says creams won't solve all of it.
Health authorities are warning people off unregulated peptides as emergency departments report a rise in severe allergic reactions.
The NEJM study of 2,339 people without diabetes also found less knee osteoarthritis pain and fewer sleep apnea events on the drug than on placebo.
A Hyderabad hospital gives a general overview of semaglutide and tirzepatide for weight management and who might be a fit.
Loading…